Coverage
-
March 02, 2021
A longtime biotech executive pled guilty Tuesday to trading on confidential information to get out ahead of the market and reel in profits when he learned of a planned 2017 acquisition of Dimension Therapeutics.
1 other articles on this case.
View all »